Volcano announces first human use of its OCT imaging catheter

May 8, 2008, San Diego, CA--The first human procedure using the Volcano optical coherence tomography (OCT) imaging catheter has been performed by Dr. Patrick Serruys at the Thoraxcenter (Rotterdam, Netherlands). Volcano OCT is designed to complement the company's line of IVUS imaging catheters and pressure guidewires used for coronary imaging and lesion assessment.

Volcano acquired the OCT technology through its purchase of CardioSpectra at the end of 2007.

"Volcano is committed to being the leader in intravascular imaging, both to complement everyday PCI technique, and to further the understanding of atherosclerotic disease progression," said Scott Huennekens, president and CEO of Volcano. "Our investment in this OCT product line underscores that commitment, and opens a series of new clinical applications and opportunities to complement our existing product line. We are delighted to be underway with our OCT effort just four months after completing the acquisition."

Volcano is working to incorporate OCT functionality into its s5i IVUS platform, as well as standalone OCT systems. Volcano's OCT imaging platform provides high-resolution images in the 10-15 micron range, opening the door for new applications to complement both IVUS and angiography.

"The high resolution OCT images provide a glimpse at structural detail not seen before by other imaging modalities," said Michel Lussier, president of Volcano Europe. "We believe that OCT has the potential to identify thin-cap fibro-atheromas, clearly highlight intraluminal thrombus, and assess the complete healing of novel drug-eluting stent designs. Volcano is committed to exploring the various clinical benefits of our OCT platform through detailed data-driven study design and mutually beneficial partnerships with other therapy companies."


Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

NIR spectroscopy intravascular imaging system receives $25M investment

Medical device maker Infraredx has received a $25 million equity investment from Nipro Corporation, which builds on an exclusive agreement between the two companies for distribution of Infraredx's ...

OCT pioneer Fujimoto selected as 2014 IEEE Photonics Award winner

James Fujimoto, the Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (MIT), has been selected for the 2014 IEEE Photonics Award.

OCT combo system receives FDA clearance, begins shipping worldwide

Ophthalmic device maker Optovue has received FDA 510(k) clearance for its iFusion combination system, which pairs the company's iVue spectral-domain optical coherence tomography (SD-OCT) system and...

OCT symposium emphasizes key applications

Overviews of biomedical imaging in general, and optical coherence tomography (OCT) in particular, kicked off the first international symposium hosted last week by the Center for Biomedical OCT Rese...

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World